TIDMMDST 
 
RNS Number : 4635U 
Medicsight Plc 
25 June 2009 
 

 
+----------------------------------+-------------------------------------+ 
| Press Release                    |                        25 June 2009 | 
+----------------------------------+-------------------------------------+ 
 
 
Medicsight PLC 
 
 
("Medicsight" or "the Company") 
 
 
Global agreement with Alma IT Systems 
Medicsight PLC (AIM:MDST), industry leader in the development of Computer-Aided 
Detection (CAD) and image analysis software which assists in the early detection 
and diagnosis of disease, is pleased to announce it has signed a non-exclusive, 
software license and distribution agreement  with Alma IT Systems ("Alma"), a 
leading developer of advanced digital medical imaging tools,  across Europe and 
South America. This will give Medicsight access to Alma's large and established 
installed base of radiology customers in key markets. 
As part of this agreement Medicsight's ColonCAD API 4.0 software will be 
integrated into Alma's latest Colon viewer, a 3D visualisation workstation which 
interprets computed tomographic colonography (CTC) image data. Alma is one of 
Spain's market leaders in medical imaging technology. It is anticipated that the 
new product will be offered to both clinicians and PACS customers via the ALMA 
3D workstation and server-based client platforms. 
Commenting on the partnership Jacobo Gil de Biedma, co-founder and CEO of Alma 
IT Systems, said "Alma is a market leader in medical imaging software in 
Spain and we are quickly gaining market share in Europe and South America.  We 
are seeing a growing demand for CT colonography imaging tools.  By developing 
the latest Alma Colon viewer with the integration of Medicsight's latest 
ColonCAD application, we can offer our clients complete, fast and reliable 
 imaging technology and continue to consolidate the ALMA 3D platform as a 
one-stop solution". 
Allan Rowley, Chief Executive of Medicsight commented "This agreement provides 
Medicsight with an ideal commercial opportunity to work with Alma and further 
extend our reach into the European and South American medical imaging markets. 
We look forward to the swift roll out of the integrated technology". 
The prototype Alma 3D Colon viewer is available for demonstration on the 
Medicsight booth  (number 13) at the 20th Annual European Society of 
Gastrointestinal and Abdominal Radiology (ESGAR 2009) taking place this week in 
Valencia. 
 
 
- ENDS - 
 
 
For further information: 
+-----------------------------------------------+------------------------+ 
| Medicsight PLC                                | www.medicsight.com     | 
+-----------------------------------------------+------------------------+ 
| Allan Rowley                                  | +44 (0)20 7605 7950    | 
+-----------------------------------------------+------------------------+ 
| Daniel Stewart & Company PLC                  |                        | 
+-----------------------------------------------+------------------------+ 
| Simon Leathers / Charlotte Stranner           | +44 (0) 20 7776 6550   | 
+-----------------------------------------------+------------------------+ 
Media enquiries: 
+-----------------------------------------------+------------------------+ 
| Abchurch Communications                       | +44 (0) 20 7398 7700   | 
+-----------------------------------------------+------------------------+ 
| Heather Salmond / Stephanie Cuthbert / Simone | +44 (0) 20 7398 7718   | 
| Alves                                         |                        | 
+-----------------------------------------------+------------------------+ 
| stephanie.cuthbert@abchurch-group.com         | www.abchurch-group.com | 
+-----------------------------------------------+------------------------+ 
 
 
 
 
Notes to editors 
 
 
About 
 
 
Alma IT Systems is comprised of a group of professionals who are dedicated to 
the design and development of computer programs for the medical field. 
Located in Barcelona, Alma is the result of more than eight years of research 
with the Universitat Politècnica de Catalunya, which is currently backed by the 
Medical School of Bern. 
In collaboration with the leading departments of R&D and design, we work to 
offer medical professionals advanced tools that allow them to carry out 
diagnostics for images and pre-surgical planning on their personal computer with 
complete comfort and flexibility. 
Our ultimate goal is to develop products that offer specific tools for each 
medical specialty so that it may be possible to carry out simultaneous surgeries 
in real time. 
Alma IT Systems has implemented a Quality Management System according to the ISO 
13485 and ISO 9001 international standards certified by SGS United Kingdom 
Limited. 
 
 
Medicsight PLC is a UK-headquartered, research driven, leading developer of 
computer-aided detection (CAD) and image analysis software for the 
medical imaging market. The CAD software  automatically highlights suspicious 
areas on computerised tomography (CT) scans of the colon and lung, 
helping radiologists to identify, measure and analyse potential disease and 
early indicators of disease. Medicsight's CAD software has been validated using 
one of the world's largest and most population diverse databases of verified 
patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software 
products are seamlessly integrated with the advanced 3D visualisation 
workstations of several industry-leading imaging equipment partners. 
 
 
About Computer-Aided Detection 
With increasingly sophisticated radiological imaging hardware such as 
Multi-Detector CT scanners, radiologists are facing a growing challenge in the 
amount of detailed patient image data that they must review for each patient 
examination. Some CT scan examinations generate as many as 2000 images per 
patient. Review of this data by the radiologist is not only time-consuming but 
also prone to error due to reader fatigue. CAD software can help the reviewing 
radiologist by analysing the image data and automatically highlighting 
suspicious regions of interest for closer inspection. Without CAD software some 
potential abnormalities or areas of disease may be overlooked. This can 
be critical for diagnosis and the management of patient outcomes as early 
detection of disease greatly increases the probability of successful treatment 
and a positive therapeutic outcome. In addition to supporting individual 
radiologists CAD also has the potential to help standardise CT interpretation 
across both individuals and institutions thereby supporting population based 
screening programmes. 
 
 
 
 
About Medicsight's CAD software 
Medicsight's ColonCAD(TM) and LungCAD(TM) software use an advanced CAD algorithm 
to analyse CT scans of the colon and lung and automatically highlight suspicious 
areas that may be indicators of disease. CAD may highlight areas easily 
overlooked by the reviewing radiologist, such as small lesions or regions that 
are hidden from view behind folds in the colon or normal structures and 
surrounding tissue in the lung. 
 
 
Both CAD products seamlessly integrate with the advanced 3D visualisation 
platforms of industry-leading imaging equipment partners. The integrated systems 
provide sophisticated image viewing capabilities, including 3D reconstructed 
image data, with the added advantage of demonstrating automatic CAD findings to 
assist clinical end users in the detection and analysis of disease. This allows 
clinical end users to perform either a 'second read', where CAD findings are 
displayed to the user after completion of an initial review of the CT scan data, 
or a 'concurrent read' where CAD findings are displayed during the user's 
initial review of the original CT scan images. 
 
 
Since inception, Medicsight has developed close and lasting relationships with 
some of the world's foremost clinicians in product related areas. This provides 
the Company with a wealth of clinical expertise and dedicated clinical research 
to support ongoing product development.  Medicsight also collaborates with a 
number of leading academic institutions and clinical research  programmes 
worldwide to develop the Company's comprehensive database of population diverse 
verified patient CT scan data, thus allowing Medicsight's products to be 
validated to the highest  possible standards. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 AGRUSONRKWRNUAR
Medicsight (LSE:MDST)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Medicsight Charts.
Medicsight (LSE:MDST)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Medicsight Charts.